Health
Therapeutic PD-1 cancer vaccine shown to be safe and effective in animal study: First-in-human clinical trial will test vaccine in select cancer patients – Science Daily
A study has described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.
A study led by researchers at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC — James) described a potential therapeutic anticancer vaccine that frees suppressed cancer-killing immune cells, enabling them to attack and destroy a tumor.Published in the journal Oncoimmunology, on October 1, 2020, the findings showed that the peptide called PD1-Vaxx, a first checkpoint inhibitor vaccine, was safe and effective…
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
General22 hours agoUS stocks sink further as Donald Trump urges Americans to be ‘courageous and patient’
-
General22 hours agoDonald Trump threatens China with additional 50 per cent tariff as trade war threatens to escalate